Immunocore Holdings plc - Ordinary shares (IMCR)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Ordinary shares
Shares outstanding
49,942,911
Number of holders
45
Total 13F shares, excl. options
17,133,052
Shares change
+653,357
Total reported value, excl. options
$586,618,000
Value change
+$22,048,655
Number of buys
18
Number of sells
-20
Price
$34.24

Significant Holders of Immunocore Holdings plc - Ordinary shares (IMCR) as of Q4 2021

51 filings reported holding IMCR - Immunocore Holdings plc - Ordinary shares as of Q4 2021.
Immunocore Holdings plc - Ordinary shares (IMCR) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17,133,052 shares of 49,942,911 outstanding shares and own 34.31% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (2,520,730 shares), Rock Springs Capital Management LP (2,471,555 shares), FMR LLC (2,123,327 shares), WELLINGTON MANAGEMENT GROUP LLP (1,414,150 shares), RTW INVESTMENTS, LP (1,245,532 shares), Avidity Partners Management LP (1,230,000 shares), GENERAL ATLANTIC, L.P. (950,000 shares), Bain Capital Public Equity Management II, LLC (711,951 shares), FIRST MANHATTAN CO (509,856 shares), and BlackRock Inc. (496,182 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.